SCHEMBL29697290

SCHEMBL29697290

NC(=O)C1CN(CC2CO2)C(=O)N1

nearest known ligand 0.40

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.40
HBB P68871 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
MMP13 P45452 3/20 0.32
MMP1 P03956 2/20 0.32
DHFR P00374 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29005236 0.76 MMP13 (0.37) SMN1; SMN2MMP13MMP1
SCHEMBL11428909 0.73 TP53 (0.45) TP53HBBSMN1; SMN2DHFR
SCHEMBL29659094 0.70 MMP13 (0.33) MMP13MMP1
SCHEMBL29697284 0.69 MMP1 (0.33) MMP13MMP1
SCHEMBL29697248 0.67 PMP22 (0.35) MMP13MMP1
SCHEMBL25251069 0.66 P2RX7 (0.39)
SCHEMBL29697309 0.66 PTGES (0.35) MMP13MMP1
SCHEMBL11598636 0.63 TP53 (0.56) TP53HBBSMN1; SMN2DHFR
SCHEMBL3471790 0.63 TP53 (0.56) TP53HBBSMN1; SMN2DHFR
SCHEMBL12236182 0.62 APEX1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4010080-A1 HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF CANCER Artios Pharma Limited (GB) 2022-06-15 EP disclosed